← Back to Search

Antibiotic

Amoxicillin for Antibiotic-Associated Diarrhea

Phase 4
Waitlist Available
Led By Yelina Alvarez, MD/PhD
Research Sponsored by Rockefeller University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will investigate whether antibiotics can cause changes in the neurons and glia cells of the human intestine, which could affect gut-brain interactions leading to disorders.

Eligible Conditions
  • Antibiotic-Associated Diarrhea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of colonic submucosal glia in the colon
Number of colonic submucosal neurons in the colon
Secondary outcome measures
Changes in gene expression in submucosal glia
Changes in gene expression in submucosal neurons

Side effects data

From 2022 Phase 4 trial • 40 Patients • NCT05020327
4%
Vomiting
100%
80%
60%
40%
20%
0%
Study treatment Arm
Low Risk Patients
No Risk Patients
High Risk

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy ControlsExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Amoxicillin Oral Capsule
2023
Completed Phase 4
~10

Find a Location

Who is running the clinical trial?

Rockefeller UniversityLead Sponsor
158 Previous Clinical Trials
16,348 Total Patients Enrolled
Yelina Alvarez, MD/PhDPrincipal InvestigatorRockefeller University

Media Library

Amoxicillin (Antibiotic) Clinical Trial Eligibility Overview. Trial Name: NCT05834036 — Phase 4
Antibiotic-Associated Diarrhea Research Study Groups: Healthy Controls
Antibiotic-Associated Diarrhea Clinical Trial 2023: Amoxicillin Highlights & Side Effects. Trial Name: NCT05834036 — Phase 4
Amoxicillin (Antibiotic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05834036 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant eligibility for this study limited to those over 18 years old?

"This clinical trial requires that patients are between 18 and 75 years old. Additionally, there are 25 trials specifically for those under the age of consent as well as 7 studies dedicated to individuals over 65."

Answered by AI

Do I meet the requirements to participate in this trial?

"This medical trial is looking to enrol 10 patients with antibiotic-associated diarrhea, aged between 18 and 75."

Answered by AI

How secure is Healthy Controls for individuals?

"Given that this is a Phase 4 trial, with the treatment having already been approved by governing bodies, our team assigned Healthy Controls a score of 3 on their safety scale."

Answered by AI

Are individuals currently able to participate in this experiment?

"Affirmative. According to clinicaltrials.gov, this medical experiment is still taking partipants - it was first posted on June 13th 2023 and the details were last modified a day ago on June 12th 2023. 10 patients are being enrolled at 1 site for this trial."

Answered by AI

To what extent is the enrollment process being expanded for this investigation?

"Affirmative, the information available on clinicaltrials.gov denotes that this investigation is actively attempting to enroll patients. The study, which was initially posted on June 13th 2023, requires 10 participants from one medical centre."

Answered by AI
~5 spots leftby Apr 2025